Nondestructive testing has a wide array of application in healthcare since it is used to detect defects in material without damaging the material or making it unsuitable for use. Two common methods used are liquid penetrant testing (PT) and ultrasonic testing (UT). This techniques are used for detection of breast, lung, thyroid, and ovary cancer. Cancer is one of the major problems across the globe. The detection and identification of cancer has seen incredible improvements over the past several decades, offering a new lease on life to those who would have been out of luck in the past. Now, a new instrument invented named as MasSpec pen, designed, and built by researchers at the University of Texas at Austin, has revolutionized the detection of cancer. The MasSpec Pen identifies cancerous tissue by touch and can detect cancer easily.
Increasing prevalence of cancer, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better diagnostic methods drives the growth of the market. There are more than 100 types of cancer, which has affected human. According to cancer research the UK in 2012, 14.1 million of new cancer cases was registered globally, which is increasing continuously. According to WHO, breast cancer is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide. Prevalence of breast cancer is more common in developed countries compare with developing countries. Furthermore, rapid development in technology, increasing government support for research & development, changing lifestyle, and many adverse effects of the present diagnostic methods expected to fuel the market growth during the forecast period.
However, these types of devices has to pass all the regulatory standards and rules, which increases the approval time. The average approval time for the medical diagnostic device may vary from 5-8 years. This long approval time, high cost of the research & development and devices may hamper the market growth during the corresponding period.
The global non-destructive medical technologies market is expected to grow at a CAGR of ~ 10.8 % during the forecast period 2017-2023.
Key Players
Some of key the players in the market are Eberlin Lab (US), Carestream Health (US), General Electric Company (US), Olympus Corporation (Japan), Element Materials Technology (US), Fischer Technology Inc. (US), Magnaflux Corporation (US), Sonotron NDT (Israel), Zetec Inc. (US), Sonatest Ltd. (UK), and Eddyfi NDT Inc. (Canada).
Segmentations
The global non-destructive medical technologies market has been segmented on the basis of methods, application, products, and end user.
On the basis of methods, the market is segmented into echocardiography, medical ultrasonography, liquid penetrant, phased array ultrasonic testing, and digital radiography.
On the basis of equipment, the market is segmented into ultrasonic equipment, X-ray equipment, infra-red devices, and mass spectrometer.
On the basis of application, the market is segmented into diagnosis, and treatment.
On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, forensic laboratories, research organizations, and others.
Request Customization
Get a Sample
Get a Sample
Request Customization